Lung cancer and pleural mesothelioma are often confused, so it’s important to understand the key differences between them, including tumor location and treatments. Lung cancer and pleural mesothelioma ...

Malignant pleural mesothelioma (MPM) is a primary and locally aggressive tumor of the pleura. A well defined causal relationship with asbestos exposure, and an overwhelming media interest in the use ...

Dervis, A. (2025) Curative Outcome of Osteosarcoma with Associated Pleural Effusion: A Case Report —Bone Tumor with Pleural ...

Preclinical studies indicate that cavity-resident macrophages in the peritoneal and pleural spaces contribute to ...

Researchers at Wake Forest School of Medicine have discovered that a nanoparticle therapeutic enhances cancer immunotherapy and is a possible new approach in treating malignant pleural effusion (MPE).

Researchers conclude that Ephrin B2 seems to play an important role in malignant pleural mesothelioma cell lines and tumors. Malignant mesothelioma is a rare asbestos-associated malignancy with ...

IT is the unfortunate lot of some patients dying of metastatic cancer of the breast, lung, cervix and so forth to be plagued by severe dyspnea due to recurrent malignant pleural effusions. Many of ...

Nearly one in five patients with malignant pleural mesothelioma (MPM) at a Barcelona hospital contracted COVID-19 during the pandemic. In addition, those patients suffered a 75% mortality rate, ...

Please provide your email address to receive an email when new articles are posted on . Chimeric antigen receptor T-cell therapy followed by pembrolizumab appeared safe and feasible for patients with ...

A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs. In 2013, Science magazine named cancer immunotherapy the scientific breakthrough ...